Advances in CAR T cell immunotherapy for paediatric brain tumours

被引:5
作者
Rao, Padmashree [1 ]
Furst, Liam [2 ,3 ]
Meyran, Deborah [4 ,5 ,6 ,7 ]
Mayoh, Chelsea [1 ,8 ]
Neeson, Paul J. [4 ,5 ]
Terry, Rachael [1 ,8 ]
Khuong-Quang, Dong-Anh [1 ,3 ,7 ]
Mantamadiotis, Theo [2 ,9 ]
Ekert, Paul G. [1 ,3 ,4 ,5 ,8 ,10 ]
机构
[1] Childrens Canc Inst, Translat Tumour Biol, Randwick, NSW, Australia
[2] Univ Melbourne, Dept Microbiol & Immunol, Melbourne, Vic, Australia
[3] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia
[4] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia
[5] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[6] Univ Paris, Inst Rech St Louis, Inserm, Human Immunol Pathophysiol Immunotherapy HIPI Unit, Paris, France
[7] Royal Childrens Hosp, Childrens Canc Ctr, Parkville, Vic, Australia
[8] Univ New South Wales, Sch Women & Childrens Hlth, Randwick, NSW, Australia
[9] Univ Melbourne, Royal Melbourne Hosp RMH, Dept Surg, Parkville, Vic, Australia
[10] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia
基金
英国医学研究理事会;
关键词
CAR T cell; immunotherapy; paediatric brain tumour; tumour microenvironment; blood brain barrier; CYTOKINE RELEASE SYNDROME; CANCER; GLIOBLASTOMA; REGRESSION; LANDSCAPE; SURVIVAL; MUTATION; ANTIBODY; THERAPY; SYSTEM;
D O I
10.3389/fonc.2022.873722
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Brain tumours are the most common solid tumour in children and the leading cause of cancer related death in children. Current treatments include surgery, chemotherapy and radiotherapy. The need for aggressive treatment means many survivors are left with permanent severe disability, physical, intellectual and social. Recent progress in immunotherapy, including genetically engineered T cells with chimeric antigen receptors (CARs) for treating cancer, may provide new avenues to improved outcomes for patients with paediatric brain cancer. In this review we discuss advances in CAR T cell immunotherapy, the major CAR T cell targets that are in clinical and pre-clinical development with a focus on paediatric brain tumours, the paediatric brain tumour microenvironment and strategies used to improve CAR T cell therapy for paediatric tumours.
引用
收藏
页数:11
相关论文
共 86 条
[31]   Molecular characteristics and therapeutic vulnerabilities across paediatric solid tumours [J].
Jones, David T. W. ;
Banito, Ana ;
Gruenewald, Thomas G. P. ;
Haber, Michelle ;
Jaeger, Natalie ;
Kool, Marcel ;
Milde, Till ;
Molenaar, Jan J. ;
Nabbi, Arash ;
Pugh, Trevor J. ;
Schleiermacher, Gudrun ;
Smith, Malcolm A. ;
Westermann, Frank ;
Pfister, Stefan M. .
NATURE REVIEWS CANCER, 2019, 19 (08) :420-438
[32]   CAR T cell immunotherapy for human cancer [J].
June, Carl H. ;
O'Connor, Roddy S. ;
Kawalekar, Omkar U. ;
Ghassemi, Saba ;
Milone, Michael C. .
SCIENCE, 2018, 359 (6382) :1361-1365
[33]   Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma [J].
Keu, Khun Visith ;
Witney, Timothy H. ;
Yaghoubi, Shahriar ;
Rosenberg, Jarrett ;
Kurien, Anita ;
Magnusson, Rachel ;
Williams, John ;
Habte, Frezghi ;
Wagner, Jamie R. ;
Forman, Stephen ;
Brown, Christine ;
Allen-Auerbach, Martin ;
Czernin, Johannes ;
Tang, Winson ;
Jensen, Michael C. ;
Badie, Behnam ;
Gambhir, Sanjiv S. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (373)
[34]   Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells [J].
Klemm, Florian ;
Maas, Roeltje R. ;
Bowman, Robert L. ;
Kornete, Mara ;
Soukup, Klara ;
Nassiri, Sina ;
Brouland, Jean-Philippe ;
Iacobuzio-Donahue, Christine A. ;
Brennan, Cameron ;
Tabar, Viviane ;
Gutin, Philip H. ;
Daniel, Roy T. ;
Hegi, Monika E. ;
Joyce, Johanna A. .
CELL, 2020, 181 (07) :1643-+
[35]   Anti-CD19 CAR T Cells Administered after Low-Dose Chemotherapy Can Induce Remissions of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma [J].
Kochenderfer, James N. ;
Somerville, Robert ;
Lu, Lily ;
Iwamoto, Alex ;
Yang, James C. ;
Klebanoff, Christopher ;
Kammula, Udai ;
Sherry, Richard M. ;
Victoria, Shi ;
Yuan, Constance ;
Feldman, Steven ;
Feldman, Tatyana ;
Goy, Andre ;
Morton, Kathleen E. ;
Toomey, Mary Ann ;
Rosenberg, Steven A. .
BLOOD, 2014, 124 (21)
[36]   B7-H3: An Attractive Target for Antibody-based Immunotherapy [J].
Kontos, Filippos ;
Michelakos, Theodoros ;
Kurokawa, Tomohiro ;
Sadagopan, Ananthan ;
Schwab, Joseph H. ;
Ferrone, Cristina R. ;
Ferrone, Soldano .
CLINICAL CANCER RESEARCH, 2021, 27 (05) :1227-1235
[37]   Current concepts in the diagnosis and management of cytokine release syndrome [J].
Lee, Daniel W. ;
Gardner, Rebecca ;
Porter, David L. ;
Louis, Chrystal U. ;
Ahmed, Nabil ;
Jensen, Michael ;
Grupp, Stephan A. ;
Mackall, Crystal L. .
BLOOD, 2014, 124 (02) :188-195
[38]   Characterization of the immune microenvironment of diffuse intrinsic pontine glioma: implications for development of immunotherapy [J].
Lieberman, Nicole A. P. ;
DeGolier, Kole ;
Kovar, Heather M. ;
Davis, Amira ;
Hoglund, Virginia ;
Stevens, Jeffrey ;
Winter, Conrad ;
Deutsch, Gail ;
Furlan, Scott N. ;
Vitanza, Nicholas A. ;
Leary, Sarah E. S. ;
Crane, Courtney A. .
NEURO-ONCOLOGY, 2019, 21 (01) :83-94
[39]   Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours [J].
Ma, Xiaotu ;
Liu, Yu ;
Liu, Yanling ;
Alexandrov, Ludmil B. ;
Edmonson, Michael N. ;
Gawad, Charles ;
Zhou, Xin ;
Li, Yongjin ;
Rusch, Michael C. ;
Easton, John ;
Huether, Robert ;
Gonzalez-Pena, Veronica ;
Wilkinson, Mark R. ;
Hermida, Leandro C. ;
Davis, Sean ;
Sioson, Edgar ;
Pounds, Stanley ;
Cao, Xueyuan ;
Ries, Rhonda E. ;
Wang, Zhaoming ;
Chen, Xiang ;
Dong, Li ;
Diskin, Sharon J. ;
Smith, Malcolm A. ;
Auvil, Jaime M. Guidry ;
Meltzer, Paul S. ;
Lau, Ching C. ;
Perlman, Elizabeth J. ;
Maris, John M. ;
Meshinchi, Soheil ;
Hunger, Stephen P. ;
Gerhard, Daniela S. ;
Zhang, Jinghui .
NATURE, 2018, 555 (7696) :371-+
[40]   Vascular endothelial growth factor expression, vascular volume, and capillary permeability in human brain tumors [J].
Machein, MR ;
Kullmer, J ;
Fiebich, BL ;
Plate, KH ;
Warnke, PC .
NEUROSURGERY, 1999, 44 (04) :732-740